Maternal valproic acid therapy during pregnancy may cause birth defects. This study identifies a distinct pattern of facial and growth abnormalities in infants exposed to valproic acid, highlighting teratogenic risks.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: